The purpose of this review is to illustrate the ways in which molecular neurobiological investigations will contribute to an improved understanding of drug addiction and, ultimately, to the development of more effective treatments. Such molecular studies of drug addiction are needed to establish two general types of in formation: (1) mechanisms of pathophysiology, identification of the changes that drugs of abuse produce KEY WORDS: Synaptic transmission; Drug addiction; G proteins; Ventral tegmental area; Cyclic AMP; Nucleus accumbens
in the brain that lead to addiction; and (2) mechanisms of individual risk, identification of specific genetic and environmental factors that increase or decrease an individual's vulnerability for addiction. This information will one day lead to fundamentally new approaches to the treatment and prevention of addictive disorders. circa 1968-1976 . During this period of time, synaptic transmission was conceived as the release of neurotransmitter from a nerve terminal, the binding of the neurotransmitter to specmc recep tor sites on target neurons, and the resulting alterations in the conductances of specmc ion channels. The action of the neurotransmitter is then terminated by its reuptake into the nerve terminal.
... cal responses in question (see Nestler and Duman 1994; Nestler and Greengard 1994) .
As the Fourth Generation of Progress (Bloom and Kup fer, 1994 ) approaches publication, we have gained an even greater appreciation of the complexity of synap tic transmission. As shown in Figure 3 , we now know that neurotransmitter-receptor regulation of G proteins and second messenger-dependent protein phosphory lation pathways represents a small part of a neuron's intracellular regulatory machinery (see Duman and Nestler 1994 The multiple biological responses to a neurotransmitter can be divided into three main categories. In some cases, in tracellular messengers mediate the actions of some neu rotransmitters in opening or inhibiting particular ion chan nels. However, intracellular messengers mediate most of the many other actions of neurotransmitters on their target neu rons. Some are relatively short-lived and involve modulation of the general metabolic state of the neurons, their ability to synthesize or release neurotransmitter, and the functional sen sitivity of their various receptors and ion channels to various synaptic inputs. Others are relatively long-lived and are achieved through the regulation of gene expression in the tar get neurons. Thus, neurotransmitters, through the regula tion of intracellular messenger pathways and alterations in gene transcription and protein synthesis, alter the numbers and types of receptors and ion channels in target neurons, the functional activity of the intracellular messenger systems in those neurons, and even the shape and numbers of syn apses the neurons form. The fIgure is drawn to illustrate the amplmcation that intracellular messenger systems can give to neurotransmitter action: the single event of a neurotrans mitter binding to its receptor (the fIrst messenger level) can act through the second, third, fourth, etc. messenger levels to produce an increasingly wider array of physiological effects. Modmed from Hyman and Nestler 1993. It is now apparent that the brain contains many impor tant intracellular regulatory pathways in addition to those regulated directly by G proteins and second messengers. Brain contains numerous protein serine/threonine kinases that are not regulated directly by second messengers (e.g, the ERKs or MAP kinases). In addition, the brain contains numerous types of protein tyrosine kinases (that phosphorylate substrate proteins on tyrosine residues), some of which reside in the receptors for neurotrophins and most other growth factors (e.g., the trk proteins), and others that are not associated with growth factor receptors (e.g., src kinase). Each of these vari ous protein kinases are highly regulated by extracellular stim uli. The second messenger-dependent protein kinases are regulated by receptor-G protein-second messenger pathways as shown in Figure 2 . The receptor-associated protein tyro sine kinases are activated upon growth factor binding to the receptor. The second messenger-independent protein ser ine/threonine kinases and the protein tyrosine kinases that are not receptor associated seem to be regulated indirectly via the second messenger-dependent and growth factor dependent pathways as depicted in the figure. The brain also contains numerous types of protein serine/threonine and pro tein tyrosine phosphatases, not shown in the figure, which are also subject to regulation by extracellular and intracellu lar stimuli. Thus, the binding of neurotransmitter to its recep tor extracellularly results in numerous short-and long-term biological responses through the complex regulation of mul tiple intracellular regulatory pathways and the phosphoryla tion or dephosphorylation of numerous substrate proteins. ModifIed from Duman and Nestler 1994. (multiple physiological effects ) Figure 4 . Hypothetical role of G proteins and the cAMP path way in mediating some of the acute effects of heroin, cocaine, and alcohol on mesolimbic dopamine function . This model is based on the known extracellular mechanisms of action of these drugs and the known receptor and post-receptor mech anisms that would be expected to follow. The fIgure focuses on G proteins and the cAMP pathway and therefore repre sents only a small portion of the many receptor and postrecep tor mechanisms that likely mediate acute drug effects on this and other neural pathways. of abuse on the rnesolirnbic dopamine systern (Table   1) . First, direct rnanipulation of these G proteins in the NAc has been shown to regulate cocaine and heroin self-adrninistration behavior (Self et al. 1994) . In these experirnents, pertussis toxin, which inactivates Gi and Go, was administered bilaterally into the NAc. It was found that this treatrnent produces a rightward shift in the dose-response functions for both cocaine and Self et al. 1993; Miserendino and Nestler 1994; tations in the G proteins rnay represent part of the pathophysiological rnechanisrns underlying drug ad diction.
Chronic cocaine is al�o known to decrease levels of Go in the VT A , changes that correlate ternporally with the induction of locornotor sensitization (Striplin and Kalivas 1992) (see Table 1 ).
Moreover, local adrninistration of pertussis toxin into the VT A has been shown t o mimic aspects of locorno tor sensitization behavior (Steketee et al. 1991) . Table 2) . These studies have rnade use of cholera toxin, which activates Gs, and analogs of cAMP that regulate cAMP-dependent protein kinase (Self et al. 1993 ). Nestler et al. 1993; Vrana et al. 1993 ).
A ROLE FOR ALTERATIONS IN GENE EXPRESSION IN DRUG ADDICTION
Chronic cocaine treatment has also been reported re cently to regulate mRNA expression of the dopamine transporter in the VTA-NAc pathway (Cerruti et al. JunB) in the NAc and caudate/putamen (Graybiel et al. 1990; Young et al. 1991; Hope et al. 1992; Cole et al. 1992; Nguyen et al. 1992) . Induction of these proteins is associated, as would be expected, with an increase in AP-1 DNA binding activity (Young et al. 1991; Hope et al. 1992 ily (Hope et al. 1992) . A course of chronic cocaine dra matically reduces the ability of a subsequent acute exposure to the drug to induce Fos and the other im mediate early gene products. However, chronic cocaine treatment is paradoxically associated with a robust in duction of AP-1 DNA binding activity. These fIndings suggest that chronic cocaine treatment may induce differ ent types of Fos-like proteins compared to the acute sit uation. Direct support for this possibility has been ob tained recently (Hope et al., 1994) 
CONTRIBUTION OF INTRACELLULAR MESSENGER PROTEINS TO INDIVIDUAL RISK FOR DRUG ADDICTION
As more is learned of the pathophysiology of drug ad diction through the investigation of intracellular mes senger pathways, it will be possible to identify specific genetic and environmental factors that determine an individual's predilection for drug addiction. Such fac tors presumably determine drug addiction vulnerabil ity by influencing an individual's responsiveness to the multiple positively and negatively reinforcing effects of a drug of abuse after acute or chronic exposure. NEUROPSYCHOPHARMACOLOGY 1994-VOL. 11, NO.2 The importance of genetic factors in establishing individual responsiveness to drugs of abuse is indicated by differences in drug-related behaviors among differ· ent inbred animal strains (e.g., Lewis and Fischer rat s). The Lewis rat self-administers opiates, cocaine, and al cohol to a greater extent than the Fischer rat (George and Goldberg 1989) , and develops a greater degree of conditioned place preference to cocaine and morphine (Guitart et al. 1992; Kosten et al. 1994) . The Lewis rat also exhibits a greater facilitation in brain self-stimu· lation thresholds in response to cannabinoids than the Fischer rat (Gardner and Lowinson 1991) . These findings raise the possibility that the Lewis rat is inher ently more" drug-preferring" than the Fischer rat. How ever, the observation that Lewis and Fischer rats also show diff erent locomotor responses to cocaine after acute and chronic administration (George et al. 1991; Kosten et al. 1994) , raises the alternative possibility that, rather than a diff erence in drug preference per se, the two rat strains may differ in their inherent sensitivity to certain of the effects of drugs of abuse.
Interestingly, Lewis and Fischer rats show marked inherent differences in several biochemical parameters in the mesolimbic dopamine system (see Table 3 for summary). The NAc of the drug-naive Lewis rat con tains lower levels of Gi and higher levels of adenylyl cyclase and cAMP-dependent protein kinase compared to the NAc of the drug-naive Fischer rat (Guitart et al. 1993) . In this manner, the Lewis rat (as compared to the Fischer rat) resembles outbred Sprague-Dawley rats treated chronically with opiates, cocaine, or alcohol. Related studies, also summarized in Table 3 , have simi · larly shown that the VTA of the drug-naive Lewis rat (as compared to the VT A of the drug-naive Fischer rat) shows diff erent levels of a number of phosphoproteins known to be altered in Sprague-Dawley rats in the chronic drug-treated state (see Nestler 1992; . These studies support the possibility that the various intracellular messenger proteins identified could not only contribute to the pathophysiology of drug ad diction but also represent part of the biochemical mech anisms that determine inherent responsiveness to drugs of abuse, including drug preference.
The importance of environmental factors in drug addiction vulnerability is demonstrated by the well established ability of many exogenous treatments to al ter drug-related behaviors. An animal's responsiveness to a drug of abuse can be altered by prior exposure to that drug itself, to other drugs, or to environmental stimuli. For example, glucocorticoid treatment and en vironmental stress have been reported to augment the reinforcing and locomotor-activating properties of opi ates, cocaine, and amphetamine, and prior exposure to these drugs of abuse can exert the same effects (e.g., see Cole et al. 1990; Kalivas and Stewart 1991; Piazza et a1. 1991) . Genetic and environmental factors cannot be viewed as separate, independent variables; rather, it is the in teraction between the two that determines an individ ual's predilection for drug addiction. An illustration of such interactions are the fmdings that chronic exposure to drugs of abuse or to glucocorticoids produces diff er ent behavioral effects, and different biochemical adap tations in the mesolimbic dopamine system, in Lewis and Fischer rats (Guitart et al. 1992 (Guitart et al. , 1993 Ortiz and Nes tler 1993) . In this way, Lewis and Fischer rats provide a novel experimental system to investigate the specifIc genetic and environmental factors that combine to de termine the biochemical phenotype in the mesolimbic dopamine system and the various drug-related be haviors regulated via this neural pathway. The fact that Lewis and Fischer rats are genetically divergent, such that strain differences probably exist for a large num ber of genes, does not limit their usefulness in the study of drug addiction. This situation is, in fact, clinically relevant in terms of the known differences in suscepti bility to the various effects of drugs of abuse observed among people, who also differ greatly in their individual genetic makeup. Lewis and Fischer rats could be used to identify specifIc genes related to drug addiction by cross-breeding the two strains through several genera tions to identify biochemical and behavioral traits that cosegregate, followed by genetic linkage analysis. Var ious drug-regulated proteins (e.g., those shown in Fig  ure 7 ) could serve as candidate genes in these studies. These investigations in rats could be followed by genetic studies in clinical populations to determine whether the same or related genes may contribute to drug addic tion vulnerability in people. IdentifIcation of genes that predispose individuals for addiction would provide leads in the development of new therapeutic agents, revolutionize diagnostic capabilities, and enable the tar geting of preventive measures to particularly vulnera ble individuals.
CONTRIBUTIONS OF INTRACELLULAR MESSENGER PROTEINS TO DRUG DEVELOPMENT EFFORTS
As an increasing number of intracellular messenger proteins are identifIed as contributing to the pathophys iology or individual risk of drug addiction, these pro teins could be used to develop novel pharmacothera peutic agents for the treatment and prevention of drug addiction. At the very least, measures of the intracellu lar messenger proteins in rats can be used as a novel procedure by which to screen test compounds preclin ically for their potential antiaddiction properties. For example, does drug X prevent or reverse cocaine's abil ity to produce adaptations in G proteins, the cAMP pathway, etc., in the mesolimbic dopamine system? In contrast to all current drug development efforts in the area of drug addiction, which are focused on test agents with a specifIc pharmacological property (e.g., selec tive antagonism of a dopamine receptor subtype), this new screen would enable the rational testing of novel drugs with diverse pharmacological actions. It is even conceivable that the intracellular mes senger proteins themselves could be targeted by new therapeutic agents. After all, some of the most effec tive and widely used drugs are directed at intracellular messenger pathways. Aspirin and all other nonsteroi dal antiinflammatory agents inhibit cyclo-oxygenase, the fIrst enzyme in the generation of prostaglandin, leu kotriene, and endoperoxide intracellular messengers (Piomelli and Greengard 1990) . FK-506 and related im munosuppressive agents bind to a newly discovered class of protein, the immunophilins (also present at high levels in brain), that regulate the activity of specific pro tein phosphatases (see Steiner et al. 1992) . Lithium, one of the most effective psychotherapeutic agents avail able, directly regulates the activity of adenylyl cyclase, G proteins, and certain inositol phosphatases, actions that presumably result in the drug's antimanic and an tidepressant effects (see Hyman and Nestler 1993) . The targeting of intracellular messenger proteins would rep resent a dramatic departure for drug development efforts in psychiatry and would clearly be of high risk. On the other hand, such efforts offer the potential of tremendous breakthroughs; drug development efforts in psychiatry over four generations have failed to re sult in fundamentally more efficacious agents, with fun damentally new mechanisms of action, in the treatment of drug addiction or other neuropsychiatric disorders.
CONCLUSIONS
The fact that many features of drug addiction in people can be reproduced accurately in laboratory animals means that studies of drug addiction offer a unique ad vantage in the investigation of the neurobiological mechanisms underlying a complex and clinically im portant behavioral abnormality . Molecular adaptations that occur in the brain in association with drug addic tion in animal models can be related to behavioral aspects of addiction in the animals, and eventually to the clinical situation. This information will lead to an improved understanding of drug addiction and to the development of more effective treatments and preven tive measures. It is also anticipated that advances made in the fIeld of drug addiction will have important im plications for how we approach the pathophysiology and treatment of other major neuropsychiatric dis orders.
